Acutely Decompensated Heart Failure in a County Emergency Department: A Double-Blind Randomized Controlled Comparison of Nesiritide Versus Placebo Treatment

Annals of Emergency Medicine

Volumn 51, Issue 5, 2008, Pages 571-578

  Miller, Adam H ^a,b   Nazeer, Shameem ^a   Pepe, Paul ^a   Estes, Barbi ^a   Gorman, April ^b   Yancy, Clyde W ^c  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FUROSEMIDE; NESIRITIDE; PLACEBO;

ACUTE HEART FAILURE; ADULT; AFRICAN AMERICAN; ARTICLE; ASIAN AMERICAN; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIURESIS; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG INFUSION; EMERGENCY CARE; EMERGENCY WARD; EUROPEAN AMERICAN; FEMALE; FOLLOW UP; HISPANIC; HOSPITALIZATION; HUMAN; HYPOTENSION; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SYMPTOM; TREATMENT OUTCOME;

EMERGENCY SERVICE, HOSPITAL; FEMALE; HEART FAILURE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NATRIURETIC AGENTS; NATRIURETIC PEPTIDE, BRAIN; RECURRENCE;

EID: 43049090403     PISSN: 01960644     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annemergmed.2007.12.003     Document Type: Article

References (12)

1. Dargie H.J., McMurray J.J., and McDonagh T.A. Heart failure: implications of the true size of the problem. J Intern Med 239 (1996) 309-315
2. American Heart Association. Heart disease and stroke statistics: 2007 update. www.americanheart.org Accessed 2007
3. Rich M.W. Management of heart failure in the elderly. Heart Fail Rev 7 (2002) 89-97
4. Thom T., Haase N., Rosamond W., et al. Heart disease and stroke statistics: 2006 update: a report from the AHA Statistics Committee and Stroke Statistics Subcommittee. Circulation 14 (2006) e85-e151
5. Fonorrow G., Adams Jr. K.F., Abraham W.T., et al., ADHERE Scientific Advisory Committee, Study Group, and Investigators. Risk for in-hospital mortality in acute decompensated heart failure: classification and regression tree analysis. Jama 293 (2005) 572-580
6. Rame J.E., Sheffield M.A., Dries D.L., et al. Outcomes after emergency department discharge. Am Heart J 142 (2001) 714-719
7. Mills R.M., Lejemtel T.H., Horton D.P., et al. Sustained hemodynamic effects of an infusion of nesiritide (human b-type natriuretic peptide) in heart failure: a randomized, double-blind, placebo controlled clinical trial. J Am Coll Cardiol 34 (1999) 155-162
8. Colucci W.S., Elkayam U., Horton D.P., et al., Nesiritide Study Group. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. N Engl J Med 343 (2000) 246-253
9. Publication Committee for the VMAC Investigators. Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial. jama 287 (2002) 1531-1540
10. Peacock W.F., Emmerman C.L., and PROACTION Study group. Safety and efficacy of nesiritide in the treatment of decompensated heart failure in observation patients. J Am Coll Cardiol 41 suppl A (2003) 336A
11. Peacock W.F., Emmerman C.L., and Silver M.A. Nesiritide added to standard care favorably reduces systolic blood pressure compared with standard care alone in patients with acute decompensated heart failure. Am J Emerg Med 23 (2005) 327-331
12. Gheorghiade M., Abraham W.T., and Albert N.M. Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. Jama 296 (2006) 2217-2226